23andMe launches the lupus research study in collaboration with Pfizer Inc.

(Edelman) 23andMe, Inc., the leading personal genetics company, today announced the launch of the Lupus Research Study in collaboration with Pfizer Inc. The companies aim to enroll 5,000 individuals with systemic lupus erythematosus, more commonly known as lupus, into the study to help better understand the genetics of lupus. The effort is also in collaboration with the Lupus Research Institute, and in concert with Lupus Awareness Month in May.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news